Summary Surgical biopsy specimens of 179 breast carcinomas were studied by steroid-binding and immunohistochemical assays or oestrogen and progesterone receptors (ER, PR) 
Quantitation of radiolabelled oestrogen and progestin bound to tumour extract cytosol is the established technique to assay the receptors of these hormones in breast carcinoma tissue (Jensen, 1978; McGuire & Clark, 1985) . The results of such determinations have been successfully used to predict response to endocrine treatment. Moreover, steroid receptor status has been found a valuable indicator of survival and possibly of recurrence-free interval (McGuire, 1987; Fisher et al., 1988; Thorpe, 1988) .
Development of monoclonal antibodies to oestrogen and progesterone receptors (ER, PR) has enabled the introduction of immunohistochemical assay (King et al., 1985 , PerrotApplanat et al., 1987 Pertschuk et al., 1988) with some potential advantages over the steroid-binding technique (King et al., 1985; McCarty et al., 1985; Helin et al., 1988; Kinsel et al., 1989) . Results of the former assays, based on immunological recognition of antigenic epitopes on receptor molecules, have displayed moderate to excellent agreement with those of the radioligand binding assays (McCarty et al., 1985; King et al., 1985; Giri et al., 1988; Helin et al., 1989; Pertschuk et al., 1988; Kinsel et al., 1989 Histopathological and immunohistochemical analysis Tumour specimens were processed to paraffin sections and stained using standard histological procedures. The tumours were histologically classified according to the World Health Organization (WHO) nomenclature (Hartmann et al., 1981) and graded in three categories of malignancy as described by Blood and Richardson (1957) . The grading was based on subjective estimation of tubule formation, nuclear atypism and frequency of mitotic/hyperchromatic nuclear figures. Also estimated were the occurrence of tumour necrosis, epithelium to stroma ratio within the tumour (both scored 1-3) and relative cellularity of the tumour per total section area (recorded as percentage).
Immunohistochemical determination of ER was performed with the ER-ICA immunoperoxidase kit (Abbott Laboratories, Diagnostic Division, North Chicago, IL, USA) following the manufacturer's instructions. MCF-7 cells were used as positive controls. In the negative control staining, normal rat immunoglobulin replaced the monoclonal anti-ER.
PR was detected on cryostat sections using a monoclonal mouse antibody to rabbit uterine PR (Transbio, Paris, France) known to crossreact with human PR (Logeat et al., 1983) . The detailed immunoperoxidase staining procedure has been described earlier (Helin et al., 1988a (Helin et al., , 1989 . Frozen sections of rabbit uterus were used as positive controls, and negative control staining was done using non-immune mouse immunoglobulin instead of the specific antibody.
The immunoperoxidase stainings for ER and PR were semiquantitatively assessed as described by McCarty et al. (1985) . Each stained section was given a histoscore (hs, range 0-500) calculated from the formula: I:(i + 1) x P,, in which i= intensity of nuclear staining (1-4, 0 = no staining) and Pi = percentage of stained nuclei of carcinoma cells. On the grounds of our earlier studies, an hs > 100 was considered positive for ER and an hs > 40 positive for PR (Helin et al., 1988a (Helin et al., , 1989 (Vihko et al., 1980) . After counting of radioactivity, the binding data and dissociation constants (Kd) were calculated by the method of Scatchard (1949) . Nonspecific binding was corrected by means of a computer program (Isola et al., 1988) . Values equal to or higher than 10 fmol of bound 3H-oestrogen or progestin were regarded as positive. Assays with Kdk0.2 nM (ER) or ) 0.3 nM (PR) were scored negative except for the data in Figure 3 , where the cut-off in receptor concentration was the only criterion for positivity.
Statistical analyses
The concordance between the immunohistochemical and steroid-binding assays was assessed with the kappa statistics (Fleiss, 1981) in which a kappa-coefficient = 0 indicates chance agreement and a kappa = 1 designates full agreement. The kappa test, one-way analysis of variance, and the X2 tests were calculated with the Biomedical Data Processing Software Library (BMDP, Los Angeles, CA, USA).
Results
Comparison of immunohistochemical receptor determination with steroid-binding assay The two different assays, based on either radioligand binding or on immunoperoxidase location of tissue-bound monoclonal antibodies, are compared in Table I . The receptor statuses (positive or negative), defined by the two assays, agreed in 82 (ER) or 70 (PR) % of the cases. The kappacoefficient (95% confidence limits) for ER comparisons was 0.585 (0.521, 0.649), and for those PR 0.4 (0.331, 0.469). The immunohistochemical ER assay was somewhat more often positive than the biochemical one (123 vs 116). Among the discordant cases, those positive in immunohistochemistry and negative in DCC assay predominated. In PR determinations, the DCC assay was a little more often positive (105 vs 96), and DCC-positive, immunoperoxidase-negative assay results were the predominant discordant ones (Table I) .
The results of steroid-binding assays were divided into three categories (receptor concentration < 10, 10-50, >50 fmol mg-'). Discordant assay results were significantly less likely to occur with assays giving cytosol concentrations 
Influence of endocrine status
The results of the two ER assays disagreed significantly more often in premenopausal (n = 58) than in post-menopausal (n = 121) patients (X2 test, P = 0.03; Figure 2 ). Both types of discordance (DCC -/histo + and DCC + /histo -) were equally represented among the premenopausal patients. In 
Influence of dissociation constant
The results of the radioligand assay were divided into three groups on the basis of the binding affinity (high, medium, low binding affinity), as reflected by the dissociation constant (KId). Concordant results were highly significantly associated with high and medium binding affinity (low and medium Kd; X2 test for linear trends: ER, P<0.0001; PR, P=0.0017, Figure 3 ), whereas low binding affinity was often associated with discordance between the two assays. Further, the dissociation constant was associated with the patients' endocrine status. Post-menopausal status was more likely to associate with lower Kd values (higher binding affinity) than the premenopausal one (x2 test for linear trends: ER, P = 0.0002; PR, P = 0.0007). clonal anti-human PR antibody JZB 39 and found an agreement of 76 or 54% in two sets of breast carcinoma biopsy material. In our previous studies, the agreement has been 71-76% with the mPRI (Helin et al., 1988a (Helin et al., , 1989 , and 82% with the JZB 39 antibody (Isola et al., 1990) .
Among the discordant assay results, the immunohistochemistry-positive DCC-negative status predominated in ER determinations. This might be due to erroneously negative results in ER DCC assays, since false positive nuclear immunostaining seems very unlikely in adequately controlled immunohistochemical analysis. Most likely to contribute to these false negative results are ER assays in premenopausal women (see below). In PR assays the predominant discordant status was the immunohistochemistry-negative DCC-positive one. One reason for these 31 discordant assay results could be insensitive receptor detection by the monoclonal antibody leading to false negative immunohistochemical results. However, we have compared the monoclonal mouse anti-rabbit PR antibody used here with the recently introduced JZB 39 anti-human PR antibody and obtained results which were only slightly in favour of the latter (Isola et al., 1989) .
Figure 1 in our study shows that the immunohistochemical and steroid-binding assays disagreed often when either of them yielded low receptor contents. There were virtually no discordant results when the ER concentration was > 50 fmol mg-', or when ER or PR histoscores were > 250. Eighty per cent of the results disagreed when the cytosol PR concentration was 10-50 fmol mg-'. These results suggest that low receptor contents, especially low PR concentrations, should be taken with care as predictors of therapy response and survival. A recent prognosis study with over 1,000 patients and a follow-up of 60 months (Shek & Godolphin, 1989) demonstrated in an analysis with stratified ER DCC data that high ER levels were significantly associated with prolonged survival. Kinsel et al. (1989) reported better predictive value for immunohistochemical ER determination relative to steroidbinding assay. They stated that in the steroid-binding assays more of the negative results were in the borderline range than in the immunohistochemistry. Non-receptor steroid-binding proteins or low levels of ligand binding to nonmalignant tissue components were discussed as possible reasons.
Endocrine status is clearly associated with the likelihood of discordance between the two assay types but only in ER determinations. In this study we confirmed our previous result (Helin et al., 1988b) that ER assays are more often concordant in post-menopausal than in premenopausal patients. Interference of endogenous oestrogen with the DCC assay is one possible explanation. To support this, high plasma or serum oestradiol levels have been observed to associate with low ER concentrations (Nagai et al., 1979; Helin et al., 1988b) . Other investigators have found no such association (Fishman et al., 1977; Edery et al., 1981) . Rather than being due to occupation of ER by endogenous ligands, low ER concentrations in premenopausal patients have been examined by true down-regulation of ER synthesis in a number of studies (e.g. Saez et al., 1978) . The latter include demonstration of low ER mRNA levels in premenopausal breast carcinoma tissue (Barret-Lee et al., 1987) . Some immunohistochemical studies have also yielded lower contents of ER in receptor-positive premenopausal specimens (King et al., 1985) . The higher discordance between the assay results in premenopausal patients may thus partly reflect its dependence on receptor concentration. U2 mx prisingly high proportions of histologically unsatisfactory tumour specimens. In our study cellularity per frozen section (proportion of malignant epithelium of total sample tissue) was not related to concordance/discordance. Low epithelial cell content within the tumours was, however, significantly correlated with discordance confirming that specimens with small amounts of carcinoma cells are a problem encountered in DCC assays. Intratumour heterogeneity in receptor expression has been demonstrated by multiple sampling in numerous DCC studies (e.g. Davis et al., 1984) , and it is clearly visualised in immunohistochemical analysis. High histoscore values correspond to little heterogeneity in receptor expression and they were correlated with high degree of concordance between the two assay types in our work (Figure lb) .
Subjectivity of interpretation may interfer with semiquantitative immunohistochemical analysis similarly to conventional morphological examination. The latter has displayed unexpectedly low interobserver reproducibility in some studies on breast carcinoma histopathology (Gilchrist et al., 1985; Davis et al., 1986) . Computerised image analysis may increase the objectivity of immunohistochemical analysis.
Studies focused on therapy response and survival are needed to assess the biological relevance and clinical value of immunohistochemical steroid receptor determination and its usefulness in comparison with conventional steroid-binding assay. In particular, the predictive value of receptor heterogeneity, revealed by routine immunohistochemical analysis, is of interest.
